ArticleCancer immunology, immunotherapy : CII2023

A phase I prospective, non-randomized trial of autologous dendritic cell-based cryoimmunotherapy in patients with metastatic castration-resistant prostate cancer.

Liv Cecilie Vestrheim Thomsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.